Severe acute respiratory syndrome: clinical outcome and prognostic correlates - PubMed (original) (raw)
Severe acute respiratory syndrome: clinical outcome and prognostic correlates
Ping Tim Tsui et al. Emerg Infect Dis. 2003 Sep.
Abstract
Severe acute respiratory syndrome (SARS) poses a major threat to the health of people worldwide. We performed a retrospective case series analysis to assess clinical outcome and identify pretreatment prognostic correlates of SARS, managed under a standardized treatment protocol. We studied 127 male and 196 female patients with a mean age of 41+14 (range 18-83). All patients, except two, received ribavirin and steroid combination therapy. In 115 (36%) patients, the course of disease was limited. Pneumonitis progressed rapidly in the remaining patients. Sixty-seven (21%) patients required intensive care, and 42 (13%) required ventilator support. Advanced age, high admission neutrophil count, and high initial lactate dehydrogenase level were independent correlates of an adverse clinical outcome. SARS-associated coronavirus caused severe illnesses in most patients, despite early treatment with ribavirin and steroid. This study has identified three independent pretreatment prognostic correlates.
Figures
Figure 1
Relationship between age and fatal severe acute respiratory syndrome illness, Hong Kong, 2003.
Figure 2
Relationship between neutrophil count and fatal severe acute respiratory syndrome illness, Hong Kong, 2003.
Figure 3
Relationship between lactate dehydrogenase level (LDH) and fatal severe acute respiratory syndrome illness, Hong Kong, 2003
Similar articles
- Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study.
Li SS, Cheng CW, Fu CL, Chan YH, Lee MP, Chan JW, Yiu SF. Li SS, et al. Circulation. 2003 Oct 14;108(15):1798-803. doi: 10.1161/01.CIR.0000094737.21775.32. Epub 2003 Sep 22. Circulation. 2003. PMID: 14504188 - Clinical trials and novel pathogens: lessons learned from SARS.
Muller MP, McGeer A, Straus SE, Hawryluck L, Gold WL. Muller MP, et al. Emerg Infect Dis. 2004 Mar;10(3):389-94. doi: 10.3201/eid1003.030702. Emerg Infect Dis. 2004. PMID: 15109402 Free PMC article. - High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome.
Ho JC, Ooi GC, Mok TY, Chan JW, Hung I, Lam B, Wong PC, Li PC, Ho PL, Lam WK, Ng CK, Ip MS, Lai KN, Chan-Yeung M, Tsang KW. Ho JC, et al. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1449-56. doi: 10.1164/rccm.200306-766OC. Epub 2003 Aug 28. Am J Respir Crit Care Med. 2003. PMID: 12947028 - [Severe acute respiratory syndrome: the first transmissible disease of the 21st century].
Nicastri E, Petrosillo N, Macrì G, Ippolito G. Nicastri E, et al. Recenti Prog Med. 2003 Jul-Aug;94(7-8):295-303. Recenti Prog Med. 2003. PMID: 12868234 Review. Italian. - Severe acute respiratory syndrome.
Chan-Yeung M, Ooi GC, Hui DS, Ho PL, Tsang KW. Chan-Yeung M, et al. Int J Tuberc Lung Dis. 2003 Dec;7(12):1117-30. Int J Tuberc Lung Dis. 2003. PMID: 14677886 Review.
Cited by
- Navigating Uncertainty with Compassion: Healthcare Assistants' Reflections on Balancing COVID-19 and Routine Care through Adversity.
Yip A, Yip J, Tsui Z, Smith GD. Yip A, et al. Healthcare (Basel). 2024 Aug 5;12(15):1544. doi: 10.3390/healthcare12151544. Healthcare (Basel). 2024. PMID: 39120247 Free PMC article. - Pulmonary Function, Computed Tomography Lung Abnormalities, and Small Airway Disease after COVID-19: 3-, 6-, and 9-Month Follow-Up.
Kłos K, Jaskóła-Polkowska D, Plewka-Barcik K, Rożyńska R, Pietruszka-Wałęka E, Żabicka M, Kania-Pudło M, Maliborski A, Plicht K, Angielski G, Wojtyszek A, Jahnz-Różyk K, Chciałowski A. Kłos K, et al. J Clin Med. 2024 May 7;13(10):2733. doi: 10.3390/jcm13102733. J Clin Med. 2024. PMID: 38792275 Free PMC article. - In silico Evaluation of NO-Sartans against SARS-CoV-2.
Omidkhah N, Hadizadeh F, Ghodsi R, Kesharwani P, Sahebkar A. Omidkhah N, et al. Curr Drug Discov Technol. 2024;21(6):e050324227669. doi: 10.2174/0115701638279362240223070810. Curr Drug Discov Technol. 2024. PMID: 38445698 - Factors Affecting Hospitalization Length and in-Hospital Death Due to COVID-19 Infection in Saudi Arabia: A Single-Center Retrospective Analysis.
Al Omair OA, Essa A, Elzorkany K, Shehab-Eldeen S, Alarfaj HM, Alarfaj SM, Alabdulqader F, Aldoughan A, Agha M, Ali SI, Darwish E. Al Omair OA, et al. Int J Gen Med. 2023 Aug 1;16:3267-3280. doi: 10.2147/IJGM.S418243. eCollection 2023. Int J Gen Med. 2023. PMID: 37546239 Free PMC article. - Dynamic alterations in white blood cell counts and SARS-CoV-2 shedding in saliva: an infection predictor parameter.
Aghbash PS, Rasizadeh R, Shirvaliloo M, Nahand JS, Baghi HB. Aghbash PS, et al. Front Med (Lausanne). 2023 Jun 15;10:1208928. doi: 10.3389/fmed.2023.1208928. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37396915 Free PMC article.
References
- Centers for Disease Control and Prevention. SARS coronavirus sequencing. [Accessed May 26, 2003] Available from: URL: http://www.cdc.gov/ncidod/sars/sequence.htm
- WHO. Interim guidelines for national SARS preparedness. [Accessed May 26, 2003] Available from: URL: http://www.wpro.who.int/sars/interim_guidelines/interim_guidelines_26May...
- Department of Health. HKSAR. Outbreak of severe acute respiratory syndrome (SARS) at Amoy Gardens, Kowloon Bay, Hong Kong. [Accessed June 2, 2003] Available from: URL: http://www.info.gov.hk/info/ap/pdf/amoy_e.pdf
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous